Skip to main content

Peer Review reports

From: Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment

Original Submission
31 Dec 2016 Submitted Original manuscript
9 Jul 2017 Author responded Author comments - Jianya Zhou
28 Feb 2017 Reviewed Reviewer Report - Christine Fillmore Brainson
22 Feb 2017 Reviewed Reviewer Report - Herbert Loong
Resubmission - Version 2
9 Jul 2017 Submitted Manuscript version 2
8 Oct 2017 Author responded Author comments - Jianya Zhou
14 Sep 2017 Reviewed Reviewer Report - Herbert Loong
Resubmission - Version 3
8 Oct 2017 Submitted Manuscript version 3
Publishing
30 Oct 2017 Editorially accepted
3 Jan 2018 Article published 10.1186/s12885-017-3720-8

You can find further information about peer review here.

Back to article page
\